AUTL: Autolus Therapeutics plc - American Depositary Shares

2.42 USD 0.09 (3.59%)

Setor: Cuidados de saúde Base: US Dollar Moeda de lucro: US Dollar

A taxa do AUTL para hoje mudou para -3.59%. Paralelamente, o preço mais baixo no mercado atingiu 2.33 e o mais alto foi 2.52.

Veja a dinâmica do par de moedas Autolus Therapeutics plc - American Depositary Shares. As cotações em tempo real ajudam a reagir rapidamente aos movimentos do mercado. Ao alternar entre os diferentes períodos de tempo, você pode monitorar tendências e movimentos de preços por minuto, hora, dia, semana ou mês. Use estas informações para prever os movimentos do mercado e tomar decisões de negociação informadas.

Tela cheia

AUTL Notícias

Investing 11:07 European Commission approves Autolus’ cell therapy for adult leukemia
Benzinga 12:36 FDA Eases Access To Life-Saving Gene Therapies For Blood Cancers - Johnson & Johnson (NYSE:JNJ), Novartis (NYSE:NVS), Gilead Sciences (NASDAQ:GILD), Bristol-Myers Squibb (NYSE:BMY)
Investing 12:01 obe-cel shows durable remission in r/r B-ALL patients at 3-year mark
Investing 06:12 Autolus Therapeutics Presents Long-Term Follow Up from the FELIX Study Demonstrating Obe-Cel’s Potential for Long-Term Remission in R/R B-ALL at the 2025 European Hematology Association (EHA) Congress
Investing 06:12 Autolus Therapeutics Presents Long-Term Follow Up from the FELIX Study Demonstrating Obe-Cel’s Potential for Long-Term Remission in R/R B-ALL at the 2025 European Hematology Association (EHA) Con
Investing 19:34 Autolus at Goldman Sachs Conference: Strategic Focus on Alcatsol Launch
Seeking Alpha 15:09 Autolus: A Buy Before Key Data Readout, Potential Expansion Into Autoimmune Market (AUTL)
Investing 11:04 Autolus shares surge 77% following InvestingPro’s April Fair Value signal
Investing 14:35 Credo Tech, Dollar General lead market cap stock movers on Tuesday
Investing 20:24 Autolus Therapeutics to Participate in Upcoming Investor Conferences
Investing 12:37 EMA committee endorses Autolus’ leukemia therapy obe-cel
Investing 13:40 Autolus Therapeutics Presents Clinical Data Updates at the 2025 European Hematology Association (EHA) Congress
Seeking Alpha 15:21 Autolus Therapeutics: Beaten Down, Cash Rich, Poised To Launch A CAR-T Cell Therapy (NASDAQ:AUTL)

Faixa diária

2.33 2.52

Faixa anual

1.11 5.01

Fechamento anterior: 2.51
Open: 2.51

Bid: 2.42
Ask: 2.72

Low: 2.33
High: 2.52

Volume: 3.498 K

Mudança diária: -3.59%
Mudança mensal: 7.08%

Mudança de 6 meses: 10.00%
Mudança anual: -49.05%

30 julho, quarta-feira